- Male or female subjects 18-60 years allergic to ragweed pollen.
- Subjects with appropriate symptom scores following exposure to ragweed in the
environmental exposure unit.
- Subjects with significant diseases other than allergic rhinitis that may interfere
with the safety or efficacy of PF-03654764.
- Subjects with significant symptoms of allergic rhinitis within the 2 weeks prior to